Print


Monday Tuesday Wednesday Thursday
 
Preliminary Scientific Programme

Wednesday, 29 June

 
Lunch (Hall C1) 12.00 – 13.30
Poster Session will be manned during the lunch hours
 
Coffe break 10.00 – 10.30, 15.00 – 15.30
 
 
 
Sherlock Holmes in Allergy
 
Room: Auditorium
09.30 – 10.00

Sherlock Holmes in Allergy 3
Case presentations
Moderators:
DENNIS NOWAK, Munich, Germany
TILMANN OPPEL, Munich, Germany
A farmer with work-related rhinitis
BETTINA HASFORD, Munich, Germany
A retired female metal worker develops airway obstruction
PETER ANGERER, Munich, Germany
Cold urticaria with a dramatic and living cause
PIA SCHÖPF, Munich, Germany
Amalgam(ated) toxicity and allergy
TILMANN OPPEL, Munich, Germany
Dangerous reactions after eating a croissant
WOLFGANG PFÜTZNER, Munich, Germany
 
 
 
Meet the Expert
 

Room 11 A
12.15 – 13.15

How do we Manage   Environmental Control

ADNAN CUSTOVIC, United Kingdom
KARLA ARRUDA, Ribeiraro Preto, Brazil
 
Room: 11 B
12.15 – 13.15
How do we Manage Difficult Asthma in Adults
PETER HOWARTH, Southampton, United Kingdom
ELISABETH BEL, Leiden, The Netherlands
 
Room 12 A
12.15 – 13.15

How do we Manage Urticaria
TORSTEN ZUBERBIER, Berlin, Germany
JORGE MASPERO, Buenos Aires, Argentina
 
Room: 12 B
12.15 – 13.15

How do we Manage Bioethics
CHRISTOF NEKAM, Budapest, Hungary
KALLIOPI KANTOU-FILI, Athens, Greece
 
 
 
Speakers’ Corner
 
Room: C1
12.30 – 13.00

Debate of the Day 2
Can Allergy be Prevented by Feeding Strategies?
Moderator:
BENGT BJÖRKSTÉN, Stockholm, Sweden
ULRICH WAHN, Berlin, Germany
ANDREA VON BERG, Wesel, Germany
 
 
 
Plenary Session
 
Room: Auditorium
10.30 – 12.00

Plenary Session 3
Cells in Allergy and How They React
Moderators:
GIANNI MARONE, Naples, Italy
ALLEN KAPLAN, Charleston, United States
Introduction into the pathophysiology of allergy
ANTHONY FREW, Southampton, United Kingdom
Chemokines and allergy
MASSIMO LOCATI, Milano, Italy
T cell apoptosis and autoimmunity
PETER KRAMMER, Heidelberg, Germany
Subtleties of signaling by peptide-MHC complexes
JOHANN DEISENHOFER, Dallas, United States
 
 
 
WAO House of Delegates
Room: 13
12.45– 15.00

WAO House of Delegates

 
 
 
Symposia
 
Room: 14 B
08.30 – 10.00
Symposium 12
Non-Injective Immunotherapy
Moderators:
WALTER CANONICA, Genova, Italy
STEPHEN DURHAM, London, United Kingdom
Mucosal tolerance in infants
PATRICK HOLT, Perth, Australia
Mechanisms of sublingual tolerance induction
THOMAS BIEBER, Bonn, Germany
Oral immunotherapy with allergens
ERIKA JENSEN-JAROLIM, Vienna, Austria
Critical evaluation of SLIT with aeroallergens
HANS-JØRGEN MALLING, Copenhagen, Denmark
 
 
Room: 5
08.30 – 10.00
Symposium 13
Mediators
Moderators:
YOSEPH MEKORI, Kfar-Saba, Israel
MARTIN CHURCH, Southampton, United Kingdom
Mast cell proteases
RICHARD L. STEVENS, Boston, United States
Cardiac mast cells
GIANNI MARONE, Naples, Italy
Leukotriene metabolism
SVEN-ERIK DAHLÉN, Stockholm, Sweden
Chemokines in asthma
KOUJI MATSUSHIMA, Tokyo, Japan
 
 
Room: 5
13.30 – 15.00
Symposium 14
Eosinophils

Moderators:
JUDAH A DENBURG, Hamilton, Canada
AKIO MORI, Japan

Eosinophil activation by danger signals
MONIQUE CAPRON, Lille, France
Eosinophil-derived indoleamine 2,3-dioxygenase
and Th2 immune selection
REDWAN MOQBEL, Edmonton, Canada
Eosinophils in inflammation
BRUCE BOCHNER, Baltimore, United States
HES pathophysiology
HANS-UWE SIMON, Bern, Switzerland
 
 
Room: 14 B
13.30 – 15.00
Symposium 15
Atopic Eczema
Moderators:
BRUNELLO WÜTRICH, Zurich, Switzerland
ALEXANDER KAPP, Hannover, Germany
S. Aureus in atopic eczema
JEAN FRANCOIS STALDER, Nantes, France
Role of food allergy in atopic eczema
THOMAS WERFEL, Hannover, Germany
Neuropeptides in atopic eczema
ALBERTO GIANNETTI, Modena, Italy
Management of infantile eczema
JORGE MASPERO, Buenos Aires, Argentina
 
 
Room: Auditorium
13.30 – 15.00

Symposium 16
T Cells in the Centre of the Immune Response
Moderators:
CEZMI AKDIS, Davos, Switzerland
SERGIO ROMAGNANI, Florence, Italy
T cell fitness
ANTONIO LANZEVECCHIA, Bellinzona, Switzerland
T regulatory cells in immunotherapy
KURT BLASER, Davos, Switzerland
T cells and eosinophils
DOUGLAS ROBINSON, London, United Kingdom
T cells in drug allergy
WERNER PICHLER, Bern, Switzerland
 
 
 
Company Sponsored Symposia
 
Room: 14 A
08.30 – 10.00
Recent Advances in Allergy and Asthma in Europe
GA2LEN
Chairmen:
PETER BURNEY, London, United Kingdom
JEAN BOUSQUET, Montpellier, France
ANA NIETO NUEZ, EC Scientific Officer, Brussels, Belgium
Unexpected results from birth cohorts
SUSANNE LAU, Berlin, Germany
The relation between air pollution, environment and asthma
BERT BRUNEKREEF, Utrecht, The Netherlands
A pan-European prick test panel
TORSTEN ZUBERBIER, Berlin, Germany
What can GA2LEN do for you ?
PAUL VAN CAUWENBERGE, Ghent, Belgium
 
 
Room: 13
08.30 – 10.15
Allergic Rhinitis and Asthma:
Two Diseases with A Common Link
Merck Sharp & Dohme
Moderator:
J. CHRISTIAN VIRCHOW, Rostock, Germany
Asthma with Allergic Rhinitis: Targeting the One Airway
TARI HAAHTELA, Helsinki, Finland
Updating Treatment Guidelines: Report from ARIA
RUBY PAWANKAR, Tokyo, Japan
Efficacy in Treating the Co-morbid Patient
DAVID PRICE, United Kingdom
Panel Discussion
 
 
Room: 14A
13.15 – 15.00
Insights into Allergic
and other Upper Respiratory Diseases
essex pharma
Introduction and welcome
JEAN BOUSQUET, Montpelier, France
Inflammation and allergic disease: Think globally
JEAN BOUSQUET, Montpelier, France
Antihistamines: Treatment to improve life symptoms of the allergic patient
MAREK KOWALSKI, Lodz, Poland

Tangible benefits of anti-inflammatory intranasal corticosteroid treatment in allergic rhinitis and acute rhinosinusitis
ELI MELZER, San Diego, United States

Optimising treatment of chronic rhinosinusitis and nasal polyposis: The role of intranasal corticosteroid therapy
WYTSKE FOKKENS, Amsterdam, The Netherlands

Questions & Answer Session
JEAN BOUSQUET, Montpelier, France

Complimentary which will be provided
 
 
Room: 13
15.15 – 17.00
Defining the Role of ICS Monotherapy
in the Management of Asthma
ALTANA Pharma
Moderator:
MICHAEL KALINER, United States
ICS Monotherapy in Clinical Practice:
Still the Cornerstone of AsthmaTherapy?
WALTER CANONICA, Italy
The Importance of Safety in the Implementation of Asthma Therapy: Improving the Chance for Success?
MICHAEL KALINER, United States
Outcome Measures in Asthma Care: Focusing on the Patient
DAVID PRICE, United Kingdom
Panel discussion
 
 
 
Satellite Symposia
 
Room: 13
17.15 – 18.45

Caring for Atopic Children by Treatment and Prevention
UCB
Moderator:
ULRICH WAHN, Berlin, Germany
The burden of allergy from a child's perspective
HUGO VAN BEVER, Singapore
Primum non nocere: Antihistamines in children
PAUL POTTER, Cape Town, South Africa
Allergy prevention: from ABC to XYZ
JOHN O. WARNER, Southampton, United Kingdom
The arithmetics of paediatric allergy: EPAAC™ epidemiology results
ERIKA VON MUTIUS, Munich, Germany
 
 
Room: 4
17.15 – 18.45

Novel Strategies in Immunotherapy -
the Innovative Adjurant MPL
Allergy Therapeutics / Bencard Allergie GmbH
Moderator:
HARALD RENZ, Germany
Monophosphoryl-Lipid A (MPL) – a promising adjuvant in vaccine development
ROLAND SÄNGER, Munich, Germany
Update of clinical results and own experience with an innovative short-term immunotherapy
FRANCESCA PUGGIONI, Rozzano, Italy
Use of an innovative short-term immunotherapy in daily practice – results from a post marketing surveillance study
ALBERT ROGER, Badalona, Spain
The symposium is certified (Bayerische Landesärztekammer)
 
 

Room: 14 A
17.15 – 18.45

Rational Use of Sublingual Immunotherapy

Stallergenes
Moderator:
TORSTEN ZUBERBIER, Berlin, Germany
JEAN BOUSQUET, Montpelier, France
The unmet therapeutic needs in allergy respiratory disorders
JEAN BOUSQUET, Montpelier, France
Dose effect of sublingual immunotherapy
ALAIN DIDIER, France
Safety of ultra rush sublingual immunotherapy
HANS F. MERK, Aachen, Germany
 
 
 
Sister Society Symposia
 
Room: 21
13.15– 15.00
ÄDA (German College of Allergists) (In German)
Fortschritte der Allergologie in der Praxis
Moderator:
WOLFGANG REIBEN, Hamburg, Germany
ERNST METSCHEL, Cologne, Germany
Allergiepräventioni
ERNST RIETSCHEL, Cologne, Germany
Allergiediagnostik
LUDGER KLIMEK, Wiesbaden, Germany
In vitro Diagnostik
KISTEN JUNG, Erfurt, Germany
Hyposensibilisierung
WOLFGANG CZECH, Villingen, Germany
 
 
Room: 5
17.15 – 18.45
ACAAI
Future Therapies in Allergic Airways Diseases:
Modulation of IgE-mediated Events
Moderator:
MYRON ZITT, Long Island, United States
Strategies to inhibit IgE Synthesi
ZAHAIR BALLAS, Iowa City, United States
Inhibition of the immediate phase of IgE-mediated events
MICHAEL S. BLAISS, Memphis, United States
Modulation of the late consequences of IgE -triggered events
TOM CASALE, Omaha, United States
 
 
 
Workshops
 
 
Room: 14 C
08.30 – 10.00
Workshop 13
Beneficial and Harmful Effects of
Infection Regarding Allergic Diseases
Moderators:
NIKOLAOS PAPADOPOULOS, Athens, Greece
ISIL BARLAN, Istanbul, Turkey
RSV, allergy and asthma in mice
SHYAM S. MOHAPATRA, Tampa, United States
Viral infection as exacerbator of human asthma
GERHARD SCHULTZE-WERNINGHAUS/
Co-author: GERNOT ROHDE, Bochum, Germany
"Infect asthma", is there a role for bacterial vaccines?
VICTOR MOSHKEVITCH, Almaty, Kazakstan
Helicobacter pilori and allergy
NELLA PREVETE, Roccarainola, Italy
Eczema herpeticum, role of dendritic cells
ANDREAS WOLLENBERG, Munich, Germany
 
 
Room: 14 C
13.30 – 15.00
Workshop 14
Is Absolute Avoidance of a Food Allergen Essential?
The Concept of Threshold Levels in Food Allergy
Moderators:
CARSTEN BINDSLEV-JENSEN, Odense, Denmark
MICHAL KUREK, Szczecin, Poland
The concept of threshold, why it is important
SUSAN HEFLE, Lincoln, United States
Correlations between threshold levels and SPT and RAST
ANNE MONERET-VAUTRIN, Nancy, France
Threshold levels in childhood
FABIENNE RANCÉ, Toulouse, France
Analytical methods for traces of hidden allergens:
Potential and limitations
STEPHAN VIETHS, Langen, Germany
 
 
Room 4
13.30 – 15.00
Workshop 15
How Important is Mite Allergen Cross -
Reactivity in Clinical Practice?
Moderators:
RONALD VAN REE, The Netherlands
ENRIQUE FERNANDEZ-CALDAS, Spain
THOMAS PLATTS-MILLS, Charlottesville, United States
Tropical mites in the southern hemisphere
LUIS CARABALLO, Colombia
Bloomia tropicalis cross-reactivity to other mites
FOOK-TIM CHEW, Singapore, Singapore
Storage mite cross-reactivity to house dust mite
MARIANNE VAN HAGE-HAMSTEN, Stockholm, Sweden
How does cross-reactivity influence mite allergen detection?
GABRIELLE PAULI, Strasbourg, France
 
 
Room: 14C
15.30 – 17.00
Workshop 16
Dendritic Cells
Moderators:
THILO JAKOB, Munich, Germany
ANGELIKA RESKE-KUNZ, Mainz, Germany
Plasmocytoid DC in allergic contact and atopic dermatitis
NATALIJA NOVAK, Bonn, Germany
DC, prostanoids and allergy revisited
FRANCOIS TROTTEIN, Lille, France
Pollen-associated lipid mediators (PALMs) modulate dendritic cell function
CLAUDIA TRAIDL-HOFFMANN, Munich, Germany
Dendritic cells in mycobacterial infection
LEOPOLDO FLORES-ROMO, Mexico City, Mexico
 
 
Room: 5
15.30 – 17.00
Workshop 17
Occupational Hand Dermatitis:
What Can We Do for Prevention?
Moderators:
THOMAS BIEBER, Bonn, Germany
CARSTEN BINDSLEV-JENSEN, Odense, Denmark
Causes and prevention of irritant contact dermatitis
THOMAS L. DIEPGEN, Heidelberg, Germany
In vitro models for prediction of irritancy
PHIL BOTHAM, Macclesfield, United Kingdom
Role of regulatory T Cells in contact dermatitis
Zenno/Kezawa, Yokohama, Japan
Nickel allergy and hand dermatitis
PETER THOMAS, Munich, Germany
 
 
Room: 4
15.30 – 17.00
Workshop 18
Hot Topics in Allergen-Specific Immunotherapy
Moderators:
MARK LARCHÉ, London, United Kingdom
GIOVANNI PASSALACQUA, Genova, Italy
Prevention of life-threatening reactions
EMILIO ALVAREZ-CUESTA, Madrid, Spain
Practical management of ASIT
ERKKA VALOVIRTA, Turku, Finland
Recombinant allergens
FATIMA FERREIRA, Salzburg, Austria
Latex glove allergy: prospects for a hypoallergenic vaccine
ROBYN O'HEHIR, Melbourne, Australia
M. vaccae as adjuvant in ASIT
ISIL BARLAN, Istanbul, Turkey
 
 
Room: 21
15.30 – 17.00
Workshop 19
Eosinophilic Inflammation: How to Deal With it?
Moderators:
HANS-UWE SIMON, Bern, Switzerland
MONIQUE CAPRON, Lille, France
Hypereosinophilic syndrome: molecular basis, malignancy or harmless proliferation?
JAN LÖTVALL, Göteborg, Sweden
IL-5, an eosinophilic cytokine, production from a diagnostic viewpoint
AKIO MORI, Kanagawa, Japan
Chemokines and antichemokines in eosinophil activation
BERNHARD HOMEY, Düsseldorf, Germany
Anti-IL-5 versus Imatinib in the treatment of hypereosinophilic
syndrome
SABINE PLÖTZ, Munich, Germany
 
 
Room: 14 A
15.30 – 17.00
Workshop 20
Mast Cell News

Moderators:
FRANSESCA LEVI-SCHAFFER, Jerusalem, Israel
MARTIN CHURCH, Southampton, United Kingdom

Ontogeny of mast cells
MASSIMO TRIGGIANI, Naples, Italy
Signal transactions in mast cells
SANTA JEREMY ONO, London, United Kingdom
Priming of mast cells and basophils
CLEMENS DAHINDEN, Bern, Switzerland
a and ß mast cell tryptases
LAWRENCE SCHWARTZ, Richmond, United States
 
 
 
Free Communications
 
 
Room: 2
08.30 – 10.00
Free Communication 15
Epidemiology II
Moderators:
MAGNUS WICKMAN, Stockholm, Sweden
LEDIT ARDUSSO, Santa Fe, Argentina
 
 
Room: 3
08.30 – 10.00
Free Communication 16
Dermatology Mechanisms
Moderators:
GEORG STINGL, Vienna, Austria
MARTIN MEMPEL, Munich, Germany
 
 
Room: 2
13.30 – 15.00
Free Communication 17
Occupational Allergy
Moderators:
DENNIS NOWAK, Munich, Germany
SANTIAGO QUIRCE, Germany, Spain
 
 
Room: 3
13.30 – 15.00
Free Communication 18
Immunotherapy - Basic
Moderators:
KAMAL MAURICE HANNA, Egypt
THOMAS CASALE, Omaha, United States
 
 
Room: 2
15.30 – 17.00
Free Communication 19
Rhinitis - Clinical
Moderators:
SAMUEL MALKA ABBO, Caracas, Venezuela
STEPHEN DURHAM, London, United Kingdom
 
 
Room: 3
15.30 – 17.00
Free Communication 20
Paediatric Allergies
Moderators:
MICHAEL KABESCH, Munich, Germany
MOTOHIRO EBISAWA, Japan
 
 
Room: 3
17.15 – 18.45
Free Communication - Late Breaking Abstracts
Basic Science II
Moderators:
ECKARD HAMELMANN, Berlin, Germany
ANTHONY FREW, Southampton, United Kingdom
 

To the top